Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 4/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.61 |
| ▸ | CPA1 | P15085 | 2/20 | 0.58 |
| ▸ | CPA3 | P15088 | 2/20 | 0.58 |
| ▸ | CPB1 | P15086 | 1/20 | 0.58 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1101111 | 1.00 | SLC1A3 (0.61) | SLC1A3SLC1A2SLC1A1CPA1CPA3 | |
| SCHEMBL27348648 | 0.89 | SLC1A3 (0.69) | SLC1A3SLC1A2SLC1A1CPA1CPA3 | |
| SCHEMBL5081348 | 0.85 | CPA3 (0.64) | CPA1CPA3CPB1CPB2ALPI | |
| SCHEMBL5081346 | 0.85 | CPA3 (0.64) | CPA1CPA3CPB1CPB2ALPI | |
| SCHEMBL2890748 | 0.84 | SLC1A3 (0.62) | SLC1A3SLC1A2SLC1A1CPA1CPA3 | |
| SCHEMBL2890750 | 0.84 | SLC1A3 (0.62) | SLC1A3SLC1A2SLC1A1CPA1CPA3 | |
| SCHEMBL14420246 | 0.82 | SLC1A3 (0.61) | SLC1A3SLC1A2SLC1A1CPA1ALPI | |
| SCHEMBL27644705 | 0.82 | SLC1A3 (0.61) | SLC1A3SLC1A2SLC1A1CPA1ALPI | |
| SCHEMBL14420344 | 0.82 | SLC1A3 (0.61) | SLC1A3SLC1A2SLC1A1CPA1ALPI | |
| SCHEMBL27348647 | 0.81 | CPA1 (0.51) | SLC1A3SLC1A2SLC1A1CPA1CPA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103338751-A | A pharmaceutical composition | UNIV WITWATERSRAND JHB | 2013-10-02 | — | — | CN | claimed |
| EP-1203784-B1 | POLYMER, IN VIVO DEGRADABLE MATERIAL, AND USE | NOF CORP (JP) | 2008-12-10 | — | — | EP | claimed |
| EP-1203784-A1 | POLYMER, IN VIVO DEGRADABLE MATERIAL, AND USE | NOF CORPORATION (JP) | 2002-05-08 | — | — | EP | claimed |
| US-20210015770-A1 | THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR CONTROLLED DRUG DELIVERY TO THE EAR | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-01-21 | — | — | US | disclosed |
| US-8853167-B2 | Short-chain cationic polyamino acid and use thereof | NANOCARRIER CO., LTD. (JP) | 2014-10-07 | — | — | US | disclosed |
| EP-2397487-B1 | SHORT-CHAIN CATIONIC POLYAMINO ACID AND USE THEREOF | NANOCARRIER CO LTD (JP) | 2013-12-25 | — | — | EP | disclosed |
| CN-103338751-A | A pharmaceutical composition | UNIV WITWATERSRAND JHB | 2013-10-02 | — | — | CN | disclosed |
| CN-102791255-A | Micelle compositions and process for the preparation thereof | DSM IP ASSETS BV | 2012-11-21 | — | — | CN | disclosed |
| US-8211351-B2 | Resorbable polymeric medical goods with improved mechanical properties and method for producing same | SYNTHES USA, LLC (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120149649-A1 | SHORT-CHAIN CATIONIC POLYAMINO ACID AND USE THEREOF | THE UNIVERSITY OF TOKYO (JP) | 2012-06-14 | — | — | US | disclosed |
| EP-2397487-A1 | SHORT-CHAIN CATIONIC POLYAMINO ACID AND USE THEREOF | NanoCarrier Co., Ltd. (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20090030415-A1 | RESORBABLE POLYMERIC MEDICAL GOODS WITH IMPROVED MECHANICAL PROPERTIES AND METHOD FOR PRODUCING SAME | SYNTHES USA, LLC | 2009-01-29 | — | — | US | disclosed |
| EP-1203784-B1 | POLYMER, IN VIVO DEGRADABLE MATERIAL, AND USE | NOF CORP (JP) | 2008-12-10 | — | — | EP | disclosed |
| EP-1744792-A1 | RESORBABLE POLYMERIC MEDICAL GOODS WITH IMPROVED MECHANICAL PROPERTIES AND METHOD FOR PRODUCING SAME | Synthes GmbH (CH) | 2007-01-24 | — | — | EP | disclosed |
| WO-2005110506-A1 | RESORBABLE POLYMERIC MEDICAL GOODS WITH IMPROVED MECHANICAL PROPERTIES AND METHOD FOR PRODUCING SAME | SYNTHES GMBH (CH) | 2005-11-24 | — | — | WO | disclosed |
| US-6673361-B1 | BLOCK COPOLYMER COMPRISING POLYETHYLENE GLYCOL BONDED WITH MODIFIED AMINO ACID SEGMENTS; FILM FOR PREVENTING TISSUE ADHESION, ARTIFICIAL DURA MATER, SUTURES, IMPLANTS, OR BIODEGRADABLE SUSTAINED-RELEASE DRUG FOUNDATION | NOF CORPORATION (JP) | 2004-01-06 | — | — | US | disclosed |
| EP-1203784-A1 | POLYMER, IN VIVO DEGRADABLE MATERIAL, AND USE | NOF CORPORATION (JP) | 2002-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149649-A1 | SHORT-CHAIN CATIONIC POLYAMINO ACID AND USE THEREOF | SLC7A1, SLC1A5, SLC43A1 | SLC1A3 37/4885SLC1A2 40/4885SLC1A1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.